Available courses

PRINCIPAL INVESTIGATOR: Daniel Hartung; 503-494-4720

FUNDED BY: Agency for Healthcare Research and Quality 

PURPOSE: The purpose of this study is to develop and pilot test a prescription drug monitoring program (PDMP) toolkit. The toolkit is intended to help community pharmacists to identify patients for whom dispensing an opioid prescription presents a safety risk, communicating with patients at the point of care, and coordinating with the primary prescriber to maximize patient safety in the use of opioid  pain relievers.You have been invited to be in this research study because you are a pharmacist practicing at a Fred Meyer pharmacy that is pilot testing the toolkit. 

PROCEDURES: We request that you complete two online surveys that will assess current knowledge, behavior, and perceptions about using the PDMP to assess unsafe opioid prescriptions. We will send an  online survey invitation before the start of the study and following completion of the study. Each survey will take less than 15 minutes to complete. If you have any questions, concerns, or complaints regarding this study now or in the future, or you think you may have been injured or harmed by the study, contact Daniel Hartung; 503-494-4720 

RISKS: Although we have made every effort to protect your identity, there is a minimal risk of loss of confidentiality. 

BENEFITS: You may or may not benefit from being in this study. However, by serving as a subject, you may help us learn how to benefit patients in the future. 

CONFIDENTIALITY: In this study we are not receiving any identifiable information about you so there is little chance of breach of confidentiality. 

COSTS: It will not cost you anything to participate in this descriptive PDMP Pharmacy Toolkit (RESPOND) 

PARTICIPATION: This research is being overseen by an Institutional Review Board ("IRB"). You may talk to the IRB at (503) 494-7887 or irb@ohsu.edu if:• Your questions, concerns, or complaints are not  being answered by the research team.

• You want to talk to someone besides the research team.

• You have questions about your rights as a research subject.

• You want to get more information or provide input about this research. 

You may also submit a report to the OHSU Integrity Hotline online at https://secure.ethicspoint.com/domain/media/en/gui/18915/index.html or by calling toll-free (877) 733-8313 (anonymous and available 24 hours a day, 7 days a week).

You do not have to join this or any research study. If you do join, and later change your mind, you may quit at any time. If you refuse to join or withdraw early from the study, there will be no penalty or loss of any benefits to which you are otherwise entitled.

Review current opioid trends and related initiatives, and define pharmacists’ roles.